| Target Price consensus revisions : last 18 months |
|
|
|
| Evolution of the average Target Price on GILEAD SCIENCES, INC. |
|
|
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
|
Focus: Money, talent flowing into mRNA sector after COVID-19 success |
| Mean consensus |
OUTPERFORM |
| Number of Analysts |
31 |
| Average target price |
75,08 $ |
| Last Close Price |
66,54 $ |
| Spread / Highest target |
50,3% |
| Spread / Average Target |
12,8% |
| Spread / Lowest Target |
-9,83% |
Consensus revision (last 18 months)
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
